This HTML5 document contains 119 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1097/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33386878
rdf:type
wikibase:Item
schema:description
2009年論文 2009年论文 2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած мақолаи илмӣ article scientifique (publié 2009) bài báo khoa học artigo científico vitenskapelig artikkel мақолаи илмӣ 2009 nî lūn-bûn 2009年论文 επιστημονικό άρθρο article científic ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ سائنسی مضمون 2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված artikull shkencor 2009年論文 artykuł naukowy научна статия 2009年论文 2009年論文 научни чланак articol științific article scientific naučni članak სამეცნიერო სტატია научни чланак مقالة علمية 2009年论文 2009년 논문 vetenskaplig artikel מאמר מדעי artikulong pang-agham artículo científico publicado en 2009 2009年論文 научная статья 2009年论文 บทความทางวิทยาศาสตร์ vedecký článok mokslinis straipsnis videnskabelig artikel (udgivet 2009) artículu científicu espublizáu en 2009 2009年論文 مقالهٔ علمی наукова стаття, опублікована в грудні 2009 tudományos cikk vitskapeleg artikkel 2009年の論文 bilimsel makale 2009年论文 artigo científico (publicado na 2009) artigo científico (publicado na 2009) tieteellinen artikkeli articolo scientifico scientific article wetenschappelijk artikel teaduslik artikkel wissenschaftlicher Artikel vědecký článek scienca artikolo
p:P577
wds:Q33386878-313F795B-432B-4133-9AC6-456A7D54C4E3
wdt:P577
2009-12-01T00:00:00Z
p:P2093
wds:Q33386878-0AD7E3E3-5BB3-46A2-BEF1-405697AFEFE9 wds:Q33386878-7F3F160B-507B-4C4D-8AB0-875132CE4406 wds:Q33386878-4C2D9689-1ABC-44B6-8AA6-4C6CE3595F15 wds:Q33386878-E5A3DFF6-793A-456E-8F1F-5532859DEB10 wds:Q33386878-C2EF4C84-3E6A-43BE-A919-9C98EE8EE3D6 wds:Q33386878-D5952D14-8B25-48F6-A45B-61F38FFDDA4A wds:Q33386878-32DD0522-9C4A-4DEB-98C1-D93351722D95
wdt:P2093
F Anthony Greco John D Zubkus Cindy Farley Patrick B Murphy Ruben A Saez Howard A Burris David R Spigel
rdfs:label
Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer
skos:prefLabel
Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer
schema:name
Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer
p:P50
wds:Q33386878-BECA5601-6D2A-4C0A-AFE6-29A348849F7F wds:Q33386878-66910830-45B4-4324-AF0A-6C47EA9C3BB5
wdt:P50
wd:Q89724740 wd:Q73567269
p:P1476
wds:Q33386878-FE6A0C6B-F314-42C6-ABEA-4C020D71F601
wdt:P1476
Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer
p:P304
wds:Q33386878-B8474342-8124-47D1-9768-0056159E156A
wdt:P304
1555-1560
p:P31
wds:Q33386878-8B54755E-E996-413A-8FEE-E549AD7DFCC0
wdt:P31
wd:Q13442814
p:P921
wds:Q33386878-EC01AA65-53D1-48FE-8CE2-8BDFF291777D wds:Q33386878-F3B11F51-7C19-4466-934F-FE09B27364DA wds:Q33386878-DC06927C-AD67-40FC-BFA6-EE90BD7E6E0D wds:Q33386878-A8ADCD83-9BD6-4B71-9897-DFD5DFCD292C wds:Q33386878-C2B8BCC0-AC04-46D8-B42A-6AAA72FE8BA8
wdt:P921
wd:Q47912 wd:Q415588 wd:Q413299 wd:Q42824440 wd:Q412197
p:P698
wds:Q33386878-3EFD9CA3-08A1-44AF-AEAC-32CE72090854
wdtn:P698
n11:19875975
wdt:P698
19875975
p:P1433
wds:Q33386878-94290939-9EDC-4A41-B68A-40EA5CA858D8
wdt:P1433
wd:Q2448056
p:P433
wds:Q33386878-248634B5-905F-4984-B801-B0262FF02B16
p:P478
wds:Q33386878-32F436EC-23BB-4DE9-A131-A3A2E6E92929
wdt:P433
12
wdt:P478
4
p:P356
wds:Q33386878-4D0CCA77-965F-4436-8480-220A424488EF
wdtn:P356
n12:JTO.0B013E3181BBC540
wdt:P356
10.1097/JTO.0B013E3181BBC540